Papers
14
Total Citations
162
H-Index
8
About
Dr. Hideki Ishida is a leading urologic surgeon whose research centers on advancing minimally invasive surgical techniques for renal cell carcinoma and prostate cancer, with a particular focus on robot-assisted laparoscopic partial nephrectomy (RAPN). His most impactful contributions involve rigorous comparative analyses that have helped define best practices in nephron-sparing surgery. Dr. Ishida has systematically compared surgical approaches—transperitoneal versus retroperitoneal—and platforms—robot-assisted versus laparoscopic versus open—to optimize outcomes for patients at varying stages of kidney disease. His work on peritumoral pseudocapsule status, using both pathological and enhanced MDCT detection, has provided critical insights into tumor biology and surgical planning. With over 150 total citations, his studies have directly influenced clinical decision-making, particularly for complex cases such as renal transplant recipients with localized prostate cancer or allograft renal cell carcinoma. Notably, his recent investigation into neoadjuvant lenvatinib plus pembrolizumab for advanced RCC with inferior vena cava thrombus represents a pioneering step toward integrating immunotherapy with surgical management. Dr. Ishida’s research consistently bridges technical innovation with improved patient outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10